baber/WOPTO huggingface dataset:
Patent FI-20031454-A0 (FI)
Inventor: TOMPERI JUSSI
IPC: C07D333/62
Filed: 2003-10-06
Abstract: The invention relates to (hetero)arylsulfonylamino based peptidomimetics of formula (I), wherein R1, R2, R3, A, B, D, Q, k and n are defined as disclosed, or a pharmaceutically acceptable salt or ester thereof. Compounds of formula (I) possess high affinity and selectivity for the somatostatin receptor subtypes SSTR1 and/or SSTR4 and can be used for the treatment or diagnosis of diseases or conditions wherein an interaction with SSTR1 and/or SSTR4 is indicated to be useful.
Patent FI-20040022-A0 (FI)
Inventor: HAENNINEN ARI
IPC: G01M99/00
Filed: 2004-01-09
Abstract: The present invention relates to a method and a system for testing the condition of the brakes of an elevator. In the method, a test weight is set to apply to the drive machine of the elevator, by means of which weight a first torque required for driving the elevator car in the upward direction is measured. At least one of the brakes of the elevator is closed. Next, the empty elevator car is driven in the upward direction with the force of the aforesaid first torque and a check is carried out to detect movement of the elevator car. If a movement of the elevator car is detected, then the aforesaid at least one brake of the elevator is regarded as defective. The method of the present invention makes it possible to check the operativeness of the brakes of the elevator without separate maintenance visits.
Patent IL-101919-A0 (IL)
Title: Fuel mixture,its production and use
IPC: C10G3/00
Filed: 1992-05-19
Abstract: The invention concerns a fuel mixture containing at least one vegetable and/or animal oil, at least one aliphatic alcohol with 1-5 C-atoms and petrol, and which can be produced by mixing these components together. This fuel mixture is suitable for use in any kind of diesel engine without the need to undertake any conversion work, as well as being usable as heating oil.
Patent IL-111399-A0 (IL)
Title: Method for the preparation of pre-filled plastic syringes
IPC: A61M5/31
Filed: 1994-10-25
Abstract: A novel method for the preparation of a pre-filled plastic syringe, and preferably the preparation of a plastic syringe pre-filled with a diagnostic contrast agent wherein said syringe comprises as components a barrel, a tip seal capable of sealing the nozzle of the barrel and a piston capable of sliding in the barrel and sealing the open end of the barrel opposite the nozzle, comprising the steps of:   (a) providing at least one component of said syringe which is molded under conditions which are substantially free of pyrogens and viable and non-viable particulates; and   (b) filling and assembling said syringe.   <IMAGE>
Patent IL-119590-A0 (IL)
Title: Novel 7- (substituted) -9- (substituted amino(-6-demethyl -6- deoxytetracycline intermediates
IPC: C07C311/08
Filed: 1996-11-10
Abstract: Novel 7-substituted-9-(substituted amino)-6-demethyl-6-deoxytetracycline compounds having activity against a wide spectrum of organisms including organisms which are resistant to tetracyclines are disclosed. Also disclosed are intermediates and methods for making the novel compounds of the present invention.
Patent IL-119684-A0 (IL)
Title: Long lasting release nifedipine preparation
IPC: A61P9/08
Filed: 1996-11-25
Abstract: This invention provides a long-lasting release solid nifedipine preparation which exhibits clinically sufficient effect when administered once per day. ÄConstructionÜ   A press coated tablet whose core and shell each contains nifedipine, the dissolution rate of nifedipine from said tablet being   (a) in the dissolution test using a sinker according to method 2 of the dissolution test method as prescribed by the Pharmacopoeia of Japan,   after 2 hours   10-40% after 4 hours   30-65% after 6 hours   at least 55%,  and (b) in the dissolution test according to the disintegration test method as prescribed by the Pharmacopoeia of Japan,   after 3 hours   20-45% after 4 hours   30-65%. c
Patent IL-129049-A0 (IL)
Title: Extraction of energy from flowing fluids
IPC: F03B13/20
Filed: 1997-09-19
Abstract: Method and apparatus for converting the kinetic energy of a moving fluid stream into useful work by using a cascade of thin aero or hydro foils positioned therein. The foils may be provided with at least two degrees of freedom and adjacent foils move out of phase. The foils are subjected to fluid induced oscillations known as flutter. Barriers (3, 43) may be positioned upstream, above, or at sides of the apparatus for increasing efficiency by increasing the fluid velocity. A system of flywheels (17, 18) are used to increase inertia of the foils and are particularly useful with hydrofoils. A cascade of aero or hydro foils may be mechanically oscillated to transfer energy to a fluid.
Patent IL-129723-A0 (IL)
Title: Method for the production of glycerol by recombinant organisms
IPC: C12N1/15
Filed: 1997-11-10
Abstract: Recombinant organisms are provided comprising genes encoding a glycerol-3-phosphate dehydrogenase and/or a glycerol-3-phosphatase activity useful for the production of glycerol from a variety of carbon substrates. The organisms further contain disruptions in the endogenous genes encoding proteins having glycerol kinase and glycerol dehydrogenase activities.
Patent IL-143663-A0 (IL)
Title: Lock detection for multipath wireless receiver
IPC: H04B1/712
Filed: 1999-12-09
Abstract: A wireless receiver receiving multipath Wash-code symbols determines which of fingers 402, 410 have locked on a signal. Measurements of the correlation energies between the received signal and all possible symbols are stored in energy storage units 404, 412. The actual signals are combined in combiner 408. A maximum determiner 416 determines the most likely combined symbol, and an index for this symbol is fed back to the energy storage units. Lock detectors 406, 414 use the measurement for this fed-back symbol to determine whether the finger has locked onto a path. This determination is used to decide whether the next signal detected by that finger should be applied to the combiner.
Patent IL-143845-A0 (IL)
Title: A tpe composition that exhibits excellent adhesion to textile fibers
IPC: C08L23/10
Filed: 1999-10-22
Abstract: A combination of a low flexural modulus and low crystallinity polyolefin and a functionalized polyolefin were found to result in an olefin composition with excellent adhesion to metals and polar polymers (e.g. polyesters, polyamides, etc) especially fibers therefrom. When these two polyolefins were added to a thermoplastic vulcanizate (e.g. used to partially or fully replace the semicrystalline polyolefin of a thermoplastic vulcanizate), the thermoplastic vulcanizate was found to have the necessary adhesion to form fiber reinforced thermoplastic vulcanizate.
Patent IL-151858-A0 (IL)
Title: Device and method for treating urinary incontinence in females
IPC: A61F6/08
Filed: 2001-03-21
Abstract: A device for use in locally delivering and controllably releasing oxybutynin in the cervical region of a female for a period of up to 28 days. The device comprises: a ring (I) comprising trifluoropropylmethyl/dimethyl siloxane elastomer, The ring (I) has a sufficient size such that it can be inserted into a vaginal canal of the female. The device also comprises a pharmaceutical composition comprising a therapeutically effective amount of oxybutynin and an excipient. The pharmaceutical composition is inserted within the ring (I). Upon insertion of the ring (I) into the vaginal canal, a therapeutically effective amount of oxybutynin is controllably released from the ring (I) for a period of up to 28 days.
Patent IL-153641-A0 (IL)
Title: Human myeloma cell line
IPC: C12N15/09
Filed: 2001-07-09
Abstract: There is provided a human myeloma cell tine for use in a method for producing a human monoclonal antibody.
Patent IL-157893-A0 (IL)
Title: Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics
IPC: C07D211/26
Filed: 2002-03-13
Abstract: A variety of dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines are disclosed, along with processes for their preparation, medicaments containing those compounds, and methods for the use of those substances in the preparation of medicaments.
Patent IL-159874-A0 (IL)
Title: Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
IPC: C07F1/08
Filed: 2002-07-10
Abstract: Compounds of general formula (I): 
in which: R 1  is hydrogen, C 1 -C 20  alkyl, C 3 -C 10  cycloalkyl, C 4 -C 20  cycloalkylalkyl, aryl, arylalkyl, or two R 1 , taken together, form a straight or cyclic C 2 -C 10  alkylene group or an ortho disubstituted arylene; R 2  is hydrogen, C 1 -C 20  alkyl, C 3 -C 10  cycloalkyl, C 4 -C 20  cycloalkylalkyl, aryl or arylalkyl optionally substituted with functional groups which allow conjugation with a suitable molecule able to interact with physiological systems; R 3 , R 4  and R 5  are hydrogen, C 1 -C 20 alkyl, C 3 -C 10 cycloalkyl, C 4 -C 20  cycloalkylalkyl, aryl, arylalkyl; FG are carboxy, -PO 3 H 2  or -RP(O)OH groups, wherein R is hydrogen, C 1 -C 20  alkyl, C 3 -C 10  cycloalkyl, C 4 -C 20  cycloalkylalkyl, aryl, arylalkyl; and their chelates with bi-trivalent ions of the metal elements having atomic number ranging between 20 and 31, 39, 42, 43, 44, 49, and between 57 and 83, and radioisotopes chosen among  203 Pb,  67 Ga,  68 Ga,  72 As,  111 In,  113 In,  90 Y,  97 Ru,  62 Cu,  64 Cu,  52 Fe,  52m Mn,  140 La,  175 Yb,  153 Sm,  166 Ho,  149 Pm,  177 Lu,  142 Pr,  159 Gd,  212 Bi,  47 Sc,  149 Pm,  67 Cu,  111 Ag,  199 Au,  161 Tb and  51 Cr as well as the salts thereof with physiologically compatible bases or acids.
Patent IL-161886-A0 (IL)
Title: Development of inducers of udp-n-acetyl-alphad-galactosamine: polypeptide n-acetylgalactosami-nyltransferase 3(ppgantase
IPC: A61K31/739
Filed: 2004-05-09
Abstract: The present invention uncovers that mutations in GALNT3 gene encoding UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T3) cause familial tumoral calcinosis (FTC). Methods and pharmaceutical compositions useful for treating disorders associated with abnormal phosphate metabolism are provided. Specifically, inducers of GalNAc-T3 can be used to treat hyperphosphatemia related disorders such as FTC, and on the other hand, inhibitors of GalNAc-T3 can be used to treat disorders associated with hypophosphatemia, such as hypophosphatemic rickets.
Patent IL-178861-A0 (IL)
Title: Pattern discovery in a network security system
IPC: G06F21/00
Filed: 2006-10-25
Abstract: Patterns can be discovered in events collected by a network system. In one embodiment, the present invention includes collecting and storing events from a variety of monitor devices. In one embodiment, a subset of the stored events is provided to a manager as an event stream. In one embodiment, the present invention further includes the manager discovering one or more previously unknown event patterns in the event stream.
Patent RO-130309-A0 (RO)
Title: Method for evaluating stress and burnout and modelling personality using psychotherapy
Inventor: COZMAN DOINA CONSTANŢA-MARIA
IPC: A61B5/16
Filed: 2014-10-28
Abstract: The invention relates to a method for evaluating stress and professional burnout in order to prevent and fight disorders induced by occupational stress. According to the invention, the method consists in the following stages: psychological testing based on testing personality and evaluating the stress level based on questionnaires, psychiatric evaluation, neuroimagery involving investigation by means of the computed tomography, associated with the administration of contrast material or brain perfusion, electroencephalography by means of which the electric cerebral activity is graphically recorded, to determine the specific grapho-elements allowing to diagnose and assess the severity of the cortical irritative phenomenon associated with the affective-emotional disorders, the data obtained in this stage being correlated with those obtained by CT brain perfusion, hormonal dosage which assesses the concentration levels of various hormones and the secretory activity of the endocrine glands, where adrenal glands secrete the stress hormones, the cortisone having increased values in case of stress, psychological intervention by cognitive-behavioural therapy which includes in the evaluation and modelling both cognitive mechanisms of logical processing and unconscious mechanisms of affective nature and transcranial magnetic neuro-stimulation which enables the reorganization of brain regions.
Patent RO-132405-A0 (RO)
Title: Warning device indicating the presence of emitting mobile terminals in the proximity, to be used in explosive atmospheres
Inventor: DARIE MARIUS
IPC: H04K3/00
Filed: 2017-09-04
Abstract: The invention relates to a warning device meant to indicate the presence of emitting mobile terminals in the proximity, to be used in explosive atmospheres. According to the invention, the warning device comprises a receiving block (1) which receives electromagnetic signals using an antenna, a detecting block (2) dedicated to mobile communications spectrum, based on a specialized integrated circuit, a processing block (3) comprising a microcontroller that has a single analogue input for taking over the signal values from the detecting block (2) and a digital port for starting optical warning, a warning block (4) based on LED sources and meant to generate a luminous signal and an acoustic signal, and a supply block (5) meant to provide autonomous operation and to limit energy so as to prevent the assembly from being a source of ignition for the explosive atmosphere.
Patent AP-2002002552-A0 (AP)
Title: Pharmaceutical compositions providing enhanced drug concentrations.
Inventor: BABCOCK WALTER CHRISTIAN
IPC: A61K9/08
Filed: 2000-12-01
Abstract: A drug in a solubility-improved form is combined with a concentration-enhancing polymer in a sufficient amount so that the combination provides substantially enhanced drug concentration in a use environment relative to a control comprising the same amount of the same solubility-improved form of drug without the concentration-enhancing polymer.
Patent ZW-6694-A1 (ZW)
Title: High foaming rheologically stable non-irritating oral composition
Inventor: PRENCIPE MICHAEL
IPC: A61Q11/00
Filed: 1994-05-20
Abstract: An oral composition of acceptable taste substantially non-irritating to oral tissue and stable to viscosity change during storage is disclosed wherein the composition contains a surfactant system comprised of a sodium lauryl sulfoacetate surfactant purified to contain less than 18% by weight impurities and an C12-C22 alkyl glycoside.
Patent IE-910385-A1 (IE)
Title: Tetralin and chroman derivatives in the treatment of asthma, arthritis and related diseases
Inventor: JR JAMES FREDERICK EGGLER
IPC: C07D413/12
Filed: 1991-02-06
Abstract: Compounds of the formula <CHEM>  wherein R is an optionally substituted heteroaryl group such as 2-chromanyl, 2-pyridyl or 5-fluoro-2-benzothiazoyl;     X is O, S or (CH2)m; R<1> is phenyl or pyridyl, optionally substituted by one or more (C1-C3)alkyl, (C1-C3)alkoxy, carboxy or [(C1-C3)alkoxy]carbonyl groups;     n is 0, 1 or 2;     m is 1 or 2; Y and Y<1> are taken together and are oxygen, or Y and Y<1> are taken separately, Y is hydrogen and Y<1> is hydroxy or an in vivo hydrolyzable acyloxy group;     Z is CH2 NR<2>, O or S; and     R<2> is hydrogen or (C1-C3)alkyl; are useful in the treatment of asthma, arthritis and related diseases mediated by leukotrienes.
Patent LU-80509-A1 (LU)
Inventor: ALTHUIS T
IPC: C07C49/757
Filed: 1978-11-13
Abstract: Compounds of the formula   <IMAGE>   <IMAGE>  wherein R1 is hydrogen, benzyl, benzoyl, alkanoyl of 1 to 5 carbon atoms or -CO-(CH2)p-NR'R'' wherein p is 0 or an integer from 1 to 4; each of R' and R'' when taken individually is hydrogen or alkyl of 1 to 4 carbon atoms; R' and R'' when taken together with the nitrogen to which they are attached form a 5- or 6-membered heterocyclic ring selected from piperidino, pyrollo, pyrrolidino, morpholino and N-alkylpiperazino having from 1 to 4 carbon atoms in the alkyl group; R2 is selected from hydrogen, alkanoyl of 1 to 6 carbon atoms and benzoyl; R3 is selected from hydrogen, methyl and ethyl; R4 is selected from hydrogen, alkyl of 1 to 6 carbon atoms and benzyl; Z is selected from: (a) alkylene having from one to nine carbon atoms; (b) -(alk1)m-X-(alk2)n- wherein each of (alk1) and (alk2) is alkylene having from 1 to 9 carbon atoms, with the proviso that the summation of carbon atoms in (alk1) plus (alk2) is not greater than 9; m and n are each 0 or 1; X is selected from O, S, SO, and SO2; and W is selected from hydrogen, methyl, pyridyl, piperidyl, phenyl, monochlorophenyl, monofluorophenyl and   <IMAGE>   wherein W1 is selected from hydrogen, phenyl, monochlorophenyl and monofluorophenyl; a is an integer from 1 to 5 and b is 0 or an integer from 1 to 4, with the proviso that the sum of a and b is not greater than 5. Compounds I and II are useful as analgesics. Compound III is useful as an intermediate for the preparation of Compounds I and II. Intermediates for the preparation of I, II and III are disclosed. A process for the use of compounds I and II to produce analgesia is also described.
Patent MA-25083-A1 (MA)
Title: Procede de traitement thermique a basse temperature de minerais et concentres de phosphate riches en matieres organiques
Inventor: ABDELLAH CHIK
IPC: F23G7/06
Filed: 2000-03-15
Abstract: LA PRÉSENTE INVENTION CONCERNE UN PROCÉDÉ DE TRAITEMENT THERMIQUE à BASSE TEMPÉRATURE DE MINERAIS ET DE CONCENTRÉS DE PHOSPHATE RICHES EN MATIèRES ORGANIQUES. LE PHOSPHATE TRAITÉ SELON CE PROCÉDÉ EST DÉBARRASSÉ D'UNE GRANDE PARTIE DES MATIèRES ORGANIQUES ET CONSERTVE SES CARACTÉRISTIQUES TEXTURALES ET STRUCTURALES, LUI GARANTISSANT UNE BONNE RÉACTIVITÉ ET MINIMISANT L'ÉNERGIE NÉCESSAIRE à SON BROYAGE. IL PEUT eTRE FACILEMENT VALORISÉ POUR LA FABRICATION D'ACIDE PHOSPHORIQUE PAR VOIE HUMIDE ET D'ENGRAIS PHOSPHATÉS. LES MATIèRES ORGANIQUES RÉSIDUELLES QU'IL CONTIENT SONT SOUS FORME DE COKE TRèS PEU SOLUBLE DANS L'ACIDE, NE GÉNèRENT PAS DE MOUSSES ÉPAISSES ET STABLES DANS LES CUVES D'ATTAQUE ET S'ÉLIMINENT EN GRANDE PARTIE AVEC LE GâTEAU DE GYPSE AU COURS DE LA FILTRATION.
Patent MA-37751-A1 (MA)
Title: Procédé de préparation de composés d'acides aminés
Inventor: REMARCHUK TRAVIS
IPC: C07C271/22
Filed: 2015-01-09
Abstract: Cette invention concerne de nouveaux procédés de préparation et de purification de composés d'acides aminés, qui sont utiles dans la préparation des inhibiteurs d'akt utilisés dans le traitement des maladies telles que le cancer, comprenant le composé de (s)-2-(4-chlorophényl)-1-(4-((5r,7r)- 7-hydroxy-5-méthyl-6,7-dihydro-5h-cyclopenta[d]pyrimidin-4-yl)pipérazin-1-yl)-3-(isopropylamino)propan-1-one.
Patent MA-38479-A1 (MA)
Title: 3-pyrimidin-4-yl-oxazolidin-2-ones comme inhibiteurs d'idh mutante
Inventor: CHO YOUNG SHIN
IPC: C07D417/14
Filed: 2014-03-12
Abstract: L'invention concerne également des compositions contenant un composé de formule (i) et l'utilisation de ces composés dans l'inhibition de protéines idh mutantes ayant une activité néomorphe. L'invention concerne en outre l'utilisation d'un composé de formule (i) dans le traitement de maladies ou de troubles associés à ces protéines idh mutante, comprenant, sans s'y limiter, des troubles de la prolifération cellulaire, comme le cancer.
Patent MA-41228-A1 (MA)
Title: Resine brillante laquee multi usage a base de caouatchouc (pneu recycle)
Inventor: FATHI SOUKAINA
IPC: C08L83/04
Filed: 2017-10-04
Abstract: L'invention concerne la transformation de déchet de caoutchouc noir (pneus usés) après le traitement et le broyage comprend la technologie complète du pré-broyage, suivi par la séparation du fer lourd, jusqu'au broyage fin final au moyen de presses à granulats. Le procédé comprend l'étape de traitement du déchet par des étapes principaux puis ils dissolues avec un solvant de transformation. L'invention concerne le procédé de transformation proprement dit pour obtenir une résine brillante laquée multi-usage.
Patent MA-49782-A1 (MA)
Title: Mise en place d’une formule à base d’extraits végétaux riche en acides phénoliques et d’acides gras essentiels pour booster, maintenir la réponse et l’équilibre immunitaire de l'organisme.
Inventor: ISMAILI ALAOUI MY MUSTAPHA
IPC: A61K31/05
Filed: 2020-05-11
Abstract: La présente invention a pour objectif la mise en place d'une formule à base d'extraits végétaux riche en acides phénoliques et d'acides gras essentiels pour booster, maintenir la réponse et l'équilibre immunitaire de l'organisme. Des plantes chémotypées appartenant aux espèces des labiés (romarin, sauge, thym, etc.), des huiles végétales appartiennent aux familles des oléagineuses, légumineuses, renonculacées,fabacée et sapotacées (soja, arachide, argan, olives, nigelle, etc., ont été utilisées pour l'extraction des molécules biologiquement actives.
Patent MA-56277-A1 (MA)
Title: Bio-fertilisant solide organique naturel et son procédé d’obtention
Inventor: BENNANI YOUNES
IPC: C05F11/02
Filed: 2022-03-25
Abstract: L’invention concerne un compost bio fertilisant solide organique naturel à base de fumier, marc de café, écume de sucrerie, déchets verts ayant une teneur élevée en matière organique et un c/n optimal pour éviter tout blocage d’azote stimulant le développement racinaire et facilite ainsi l’alimentation des végétaux. L’invention concerne aussi un nouveau procédé d’obtention dudit compost afin que ce dernier soit exempt de nématodes, de micro-organismes pathogènes nocifs et de graines de mauvaises herbes et renferme des éléments minéraux tels que n, p, k, ca, mg qui sont libérés progressivement durant toute la durée de la culture et qui agit favorablement sur la structure et l’aération du sol. Il augmente la capacité de rétention en eau.
Patent UY-24560-A1 (UY)
Title: Derivados arilos de la pirimidina útiles como antagonistas 5ht2b selectivos
Inventor: BERGER JACOB
IPC: C07D239/47
Filed: 1997-05-22
Abstract: La presente invención se refiere a derivados de pirimidina y a sales o N-óxidos derivados farmacéuticamente aceptables, que muestran propiedades farmacológicas útiles, de uso particular como antagonistas selectivos del receptor 5HT2B, a su preparación, a composiciones farmacéuticas conteniéndolos y a su uso en el tratamiento de diversas enfermedades, especialmente de la migrana. La invención se refiere a formulaciones y métodos de tratamiento.
Patent UY-25513-A1 (UY)
Title: Composiciones sólidas que contienen gabapentina y proceso para su preparación
Inventor: AOMATSU AKIRA
IPC: C07C229/28
Filed: 1999-05-14
Abstract: La presente invención proporciona una composición farmacéutica sólida estabilizada que contiene un derivado de ácido 4-amino-3-sustituido-butanoico, incluyendo gabapentina, pregabalina, baclofeno, que puede obtenerse mediante la incorporación de un humectante como estabilizador. Dicha composición se presenta en las formas de dosificación de tabletas, polvos, gránulos y cápsulas. Asimismo, la patente se refiere a un proceso para la preparación de la misma. La gabapentina (ácido 1-(Aminometil) ciclohexanoacético) se usa como un medicamento para el tratamiento de ciertos trastornos del sistema nervioso, tales como epilepsia, enfermedad de Alzheimer o enfermedad de Parkinson.
Patent UY-28131-A1 (UY)
Title: Derivados biciclicos para el tratamiento del crecimiento celular anormal
Inventor: KATH JOHN CHARLES
Filed: 2003-12-17
Abstract: La invención se refiere a compuestos de fórmula 1 y a sales, pro fármacos y solvatos farmacéuticamente aceptables de los mismos, en la que R1, R2, R3 y R5 son como se definen en la presente memoria, y en la que el compuesto de fórmula 1 comprende opcionalmente además un sustituyente hidroxi o un ácido O-glucurónico. La invención se refiere también a procedimientos de tratamiento del crecimiento celular anormal en mamíferos mediante la administración de los compuesto de fórmula 1 y a composiciones farmacéuticas para tratar dichos trastornos que contienen los compuestos de fórmula 1. La invención se refiere también a procedimientos de preparación de los compuestos de fórmula 1.